Archives
-
Proximity Labeling of Activity-Driven Synaptic Trafficking
2026-09-01
Pascual-Caro and de Juan-Sanz developed a synaptic-cleft proximity-labeling strategy to measure activity-driven trafficking of endogenous proteins without overexpressed fluorescent tags. The method links a shortened extracellular biotinylation pulse to the rapid kinetics of synaptic vesicle exocytosis, enabling detection of transiently exposed proteins and providing direct evidence for activity-dependent surface translocation of ATG9A and NPTX1.
-
Lyso-Tracker Red: Turning Lysosome Signal into Mechanism
2026-09-01
Lyso-Tracker Red enables live-cell visualization of acidic lysosomal compartments, but its greatest value comes from interpreting signal changes alongside morphology and cell-death biology. This article presents a perturbation-aware framework grounded in renal cancer research on lysosomal membrane permeability.
-
3-Hydroxybutyrate (BHBA): Mechanisms & Workflows
2026-08-31
3-hydroxybutyrate (BHBA) is a fatty acid β-oxidation metabolite that functions as both a ketone body signaling molecule and a chromatin-regulating metabolite. Evidence supports its use in controlled ketosis, metabolic disease research, histone deacetylase studies, and mechanistic neuroprotection workflows, but ketone-body evidence from stroke models is not automatically BHBA-specific.
-
DAF-2 diacetate for NO Imaging
2026-08-31
DAF-2 diacetate converts intracellular nitric oxide activity into a retained fluorescent signal suited to live-cell imaging, comparative stress assays, and high-content workflows. Its strongest application here is translating sulfur-dependent control of reactive nitrogen species into measurable spatial and temporal readouts in soybean nodules.
-
Dual Luciferase Reporter Gene System for BMSC Studies
2026-08-30
Use paired firefly and Renilla reporters to separate pathway-dependent transcription from well-to-well variation in BMSC experiments. This workflow connects MRF–FSHR–cAMP–PKA–CREB questions with scalable promoter, response-element, and post-transcriptional reporter assays.
-
Bay 11-7085: NF-κB Workflow Guide
2026-08-29
Bay 11-7085 is a practical NF-κB activation inhibitor for connecting inflammatory signaling with apoptosis, cell-cycle arrest, and disease-relevant phenotypes. This workflow guide covers pathway validation, ER-stress experiments, endometriosis and meningitis models, plus troubleshooting for dosing, solubility, and interpretation.
-
RP3-340N1.2, IL-6, and NSCLC Progression
2026-08-28
This study identifies the long non-coding RNA RP3-340N1.2 as a post-transcriptional regulator of IL-6 mRNA stability in non-small cell lung cancer. Through loss-of-function, RNA-decay, RNA immunoprecipitation, and co-culture experiments, it connects lncRNA-mediated RNA stabilization with tumor-cell proliferation, migration, and macrophage-associated signaling.
-
ARCA Cy3 EGFP mRNA (5-moUTP) Workflow Guide
2026-08-28
ARCA Cy3 EGFP mRNA (5-moUTP) combines covalent Cy3 tracking with ARCA-capped, 5-methoxyuridine modified mRNA translation for dual-readout delivery studies. Use it to distinguish cellular uptake, intracellular localization, and EGFP reporter gene expression when optimizing lipid-based transfection in mammalian cells.
-
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus
2026-08-27
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based detection. It is intended for research applications such as in situ hybridization and Northern blotting, and should not be used for diagnostic, clinical, or therapeutic purposes.
-
HyperScribe T7 High Yield Cy3 RNA Labeling Kit Plus
2026-08-27
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus supports in vitro transcription of randomly Cy3-modified RNA probes for fluorescence-based detection. It is intended for research workflows such as in situ hybridization and Northern blotting, not diagnostic, therapeutic, or clinical use.
-
GlmS–SigB Control of S. aureus Biofilms
2026-08-26
The 2024 study identifies GlmS as an upstream regulator that connects advanced glycation end products (AGEs) with sigB-dependent virulence factor expression and biofilm formation in Staphylococcus aureus. Genetic, transcriptional, biochemical, and phenotypic experiments support a GlmS–SigB regulatory axis relevant to diabetic wound infection research, while also defining important limits for extrapolation beyond the tested strain and in vitro model.
-
Triptolide (PG490): From Transcription to Translation
2026-08-26
A mechanistic and strategic guide to using Triptolide (PG490) as a transcriptional, immune, and matrix-remodeling research tool, with experimental guidance informed by emerging work on transcription condensates and genome stability.
-
RB1 Loss and the Earliest Cell of Human Retinoblastoma
2026-08-25
This study uses RB1-deficient human retinal organoids and single-cell analysis to reconstruct how retinal cell states change before retinoblastoma becomes an overt tumor. Its central finding is that ATOH7+/RXRγ+ nascent cone precursors are the earliest cellular origin identified, while neurogenic retinal progenitor cells are the most sensitive population to RB1 loss.
-
Fluorescein Tyramide for Causal Neurobiology
2026-08-25
Fluorescein Tyramide connects ultrasensitive molecular imaging with causal circuit neuroscience. Learn how TSA-based IHC, ISH, and flow cytometry workflows can clarify oxytocin signaling changes after early-life adversity while preserving essential assay controls.
-
Phillygenin in Diabetic Nephropathy: Dual-Pathway Evidence
2026-08-24
The reference study identifies phillygenin as a candidate intervention for diabetic nephropathy and links its protective effects to coordinated suppression of TLR4/MyD88/NF-κB inflammation and restoration of PI3K/AKT/GSK3β signaling. Using high-glucose podocyte models, RNA sequencing, biochemical assays, and db/db mice, the authors connect reduced inflammatory and apoptotic responses with improved renal injury metrics.